Análisis Argos
IQV
IQVEn su precio
IQVIA Holdings Inc. · Healthcare
US$ 207.04
precio al 2026-07-04
Valor justo Argos*
US$ 163–194
vs. su valor justo
16% por encima
Score Argos
52/100
En su precio
LA RESPUESTA
El precio asume un crecimiento (11.8%) en línea con lo que la empresa demuestra (7.7%). Ni ganga ni exceso — el mercado le puso un precio razonable.
Recompensas
Cotiza 23% por debajo de su valor justo.
Riesgos
!Balance frágil: la deuda pesa sobre el negocio.
VALOR3/6FUTURO3/6PASADO3/6SALUD1/6DIVIDENDO4/6
El Iris de calidad
VALOR3/6FUTURO3/6PASADO3/6SALUD1/6DIVIDENDO4/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance frágil
DividendoDevuelve capital al accionista
Score Argos52de 100En su precio
Ingresos6%
US$ 16.3 B
Margen operativo2%
14%
Flujo de caja libre3%
US$ 2.1 B
Deuda neta
US$ 14.2 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 34.6B
P/E25.4x
EV/EBITDA14.2x
FCF yield5.9%
ROIC9.3%
Margen operativo14%
Crecim. ingresos+5.9%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 3 jul
Here's Why Investors Should Hold IQV Stock in Their Portfolios Now
IQVIA's AI tools, record R&D backlog and strong free cash flow support its outlook, but weak liquidity and no dividend remain investor concerns.
businesswire.com · 18 jun
StackAdapt Teams Up with IQVIA Digital's MediaOS to Power Healthcare Advertising
TORONTO--(BUSINESS WIRE)--StackAdapt (www.stackadapt.com), the leading AI advertising and orchestration platform, today announced a collaboration with IQVIA Digital to advance more relevant and compliant engagement with healthcare audiences. IQVIA Digital's integrated solutions enable marketers to quickly transform data-driven insights into meaningful, privacy-conscious activation across the healthcare ecosystem.Through this collaboration, StackAdapt's programmatic advertising capabilities are n.
forbes.com · 17 jun
The Healthcare M&A Wave
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
zacks.com · 17 jun
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
247wallst.com · 17 jun
Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More
Futures are trading mixed as we hit the midweek point, as the Space Exploration Technologies (NASDAQ: SPCX) or SpaceX IPO rush is starting to fade somewhat.
zacks.com · 15 jun
Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity
IQVIA Holdings gains from its vast healthcare data, AI-driven analytics & global IT infrastructure, supporting expansion and solid growth.
zacks.com · 15 jun
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
gurufocus.com · 15 jun
Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain
Wiley (NYSE: WLY) and IQVIA (NYSE: IQV) today released [url="]Scientific Discovery and AI: The Science-to-Patient Journey[/url], a cross-sector intelligence repo

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.